Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases

A McGarry Houghton1, Jay L Grisolano, Mary L Baumann

  • 1Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

Cancer Research
|June 17, 2006
PubMed

Insights

Macrophage elastase (MMP-12) suppresses lung tumor growth by creating an anti-angiogenic environment. Mice lacking MMP-12 showed increased lung metastases, indicating its protective role in cancer progression.

Area of Science:

  • Oncology
  • Tumor Microenvironment Biology
  • Cancer Metastasis Research

Background:

  • Matrix metalloproteinases (MMPs) are broadly implicated in tumor progression.
  • Recent clinical trials of synthetic MMP inhibitors have failed in cancer chemotherapy.
  • This suggests some MMPs might have a host-protective role against tumors.

Purpose of the Study:

  • To investigate the role of macrophage elastase (MMP-12) in lung tumor progression.
  • To determine if MMP-12 influences metastasis formation or tumor growth.
  • To understand the mechanism by which MMP-12 affects the tumor microenvironment.

Main Methods:

  • Utilized genetically modified mice deficient in MMP-12.
  • Employed spontaneous and experimental metastasis models of Lewis lung carcinoma.
  • Assessed tumor burden, metastasis, and microvessel density in vivo.
  • Analyzed the source of MMP-12 expression within the tumor microenvironment.

Main Results:

  • Mice deficient in MMP-12 exhibited significantly increased pulmonary metastases compared to wild-type mice.
  • MMP-12 deficiency impacted tumor growth rather than initial metastasis formation.
  • MMP-12, exclusively expressed by tumor-associated macrophages, correlated with decreased tumor microvessel density.
  • MMP-12 promoted an angiostatic tumor microenvironment, hindering tumor growth independently of angiostatin.

Conclusions:

  • Macrophage elastase (MMP-12) plays a crucial role in suppressing lung tumor growth.
  • MMP-12 acts by modulating the tumor microenvironment towards an anti-angiogenic state.
  • Targeting tumor-promoting MMPs, while sparing host-protective ones like MMP-12, may offer effective cancer therapeutic strategies.

Related Concept Videos